Advanced

Will Molecular Biology's Most Important Discovery In Years Be Ruined By Patents?

Posted by BernardSwiss on · Post a comment
Techdirt; By Glyn Moody
Mail this story
Print this story

CRISPR-Cas can be thought of as the first really powerful and general-purpose genome editor -- a GNU Emacs for DNA. It is widely expected that it will have a massive impact on molecular biology, both for pure research and in industrial applications. Given those very high stakes, it will not come as a surprise to learn that there is already a fierce tussle over who owns a key patent in this field:

Full Story

  Nav
» Read more about: Story Type: Editorial, News Story; Groups: Community, Intellectual Property, Standards

» Get new stories by e-mail: nightly or as they are published

« Return to the newswire homepage

  Related stories
» More like this

Comments

No comments yet. Be the first.

Post a comment

A free account is needed to post. Write your comment here first: your text is kept in this browser while you sign up or log in, and is waiting for you when you come back.

Your message:
|||||
10
Markdown: **bold**, *italic*, [text](https://link), - lists, > quotes, $x^2$ for math. Formatting help

Sign up and post (it is free)  or  Log in and post